AzTrials
AzTrials

Suicidal IdeationNCT05171868

Eye Movement Desensitization and Reprocessing (EMDR) for Police Personnel

A study testing Eye Movement Desensitization and Reprocessing (EMDR) in people with Suicidal Ideation and Psychological Trauma, run by Pakistan Institute of Living and Learning at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Objectives: 1. To examine the feasibility of Eye Movement Desensitization and Reprocessing (EMDR) as an intervention to reduce psychological trauma and stress amongst police officers in Pakistan. 2. To test whether reducing stress and psychological trauma reduces suicidal ideation in police officers. 3. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Suicidal Ideation, Psychological Trauma, Stress
What is being tested?
Eye Movement Desensitization and Reprocessing (EMDR)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 sitePakistan
Study dates
20 May 2022to 30 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Having suicidal ideation measured as a score > 2 on Beck scale of suicidal ideation
  • Aged 18 years - 60 years' old
  • Police officer with psychological trauma measured with the International Trauma Questionnaire and stress measured with stress subscale of Depression, Anxiety and Stress scale

Who cannot join

  • Less than 12 months' experience in the police officer.
  • Participants reporting active suicidal ideation measured as a score of 2 on item no 4 of BSSI will be excluded and referred to a psychiatric service.
  • With current history of use of hard/psychoactive substances (excluding tobacco and caffeine).
  • Unable to provide consent due to severe mental or physical illness.
  • Unlikely to be available for the entire duration of the study.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site, 1 recruiting
  • Prison settings Peshawar

    Peshawar, KPK, 25000

    Umair Ahsen

    Recruiting

Other trials in Pakistan

About this study

Official title: Eye Movement Desensitization and Reprocessing (EMDR) for Stress, Psychological Trauma and Suicidal Ideation in Police Personnel: A Feasibility Randomised Controlled Trial

Objectives:

  1. To examine the feasibility of Eye Movement Desensitization and Reprocessing (EMDR) as an intervention to reduce psychological trauma and stress amongst police officers in Pakistan.
  2. To test whether reducing stress and psychological trauma reduces suicidal ideation in police officers.
  3. To explore participants' experiences with EMDR Intervention.
Read more

Study design and setting:

The study will be a mixed-method feasibility randomized controlled trial of EMDR as an intervention in treating symptoms such as stress, trauma and suicidal ideation in police officers. The study will be conducted in five major cities in Pakistan: Rawalpindi, Karachi, Peshawar, Quetta, and Lahore.

Sample size:

A total of N=80 eligible police officers will be recruited and randomized in the study.

Read the detailed description

EMDR intervention is an evidence-based psychological intervention that has been proven effective for stress and trauma, however, research evidence on feasibility of EMDR in forensic settings in Pakistan is limited. The current study aims to establish the feasibility and acceptability of EMDR intervention for management of stress, psychological trauma and suicidal ideation amongst police officers in Pakistan. The study will recruit a total of 80 police officers from police stations in the participating study sites, and prospective participants will be screened against eligibility criteria. Eligible consented participants will be enrolled in the study. An independent statistician will randomize participants to one of the two study arms: 1) EMDR (Intervention); or 2) waiting list control arm. Each participant in the intervention arm will receive 8 individual, weekly EMDR sessions over 8 weeks. Each session will take approximately 60-90 minutes. The sessions will be delivered at a place convenient to the participants. Trained EMDR therapists will deliver the intervention. The waiting list control arm will receive their routine care as usual, As part of the safety protocol, the details of any services each participant receives in the control group will be obtained. EMDR treatment will be offered to the control group (waiting control group) after the active intervention is complete. Assessment measures will be administered before and after the intervention at 8th week. All assessments will be rater blind. After post-assessments at 8th week, a purposefully selected subset (stratified by age \& gender) of participants will be invited for qualitative interviews to explore their experiences and satisfaction with the intervention. Participants will be interviewed within 1 week of their post-intervention by a trained qualitative researcher exploring their experience with EMDR, the barriers and facilitators to engagement, and perceived benefits or negative experiences with the intervention. A sample of up to 15 interviews would be enough to achieve category saturation. On average, interviews will last for 60 minutes. The interview will be face-to-face or through telephone as an alternative to a face-to-face meeting to reduce the number of in-person meetings given the current context of COVID-19.

Being tested
Eye Movement Desensitization and Reprocessing (EMDR)
Keywords
Forensic settings, EMDR, Trauma, Police Personnel, Suicidal Ideation, Stress, Pakistan, Feasibility
Medical subject headings
Suicidal Ideation, Psychological Trauma, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye Movement Desensitization and Reprocessing (EMDR)Behavioural

    Each participant in the intervention group will receive 8 individual, weekly EMDR sessions over 8 weeks. Each session will take approximately 60-90 minutes. The sessions will be delivered at a place convenient to the participant. Trained EMDR therapists will deliver the intervention.

Study groups in NCT05171868
Study groupRoleWhat they receive
EMDR receiving groupExperimentalEMDR is a psychotherapeutic approach that emphasizes the role of the brain's information processing system in perfecting the psychological consequences of distressing events. EMDR is an eight-phase treatment protocol, including procedure that focuses on the memories underlying current problems and those that must be specifically addressed to bring the client to a robust state of psychological health. One of its distinguishing aspects is its use of bilateral physical stimulation, such as side-to-side eye movements, alternating hand taps, or alternating auditory tones while the person undergoing treatment is mentally focusing on aspects of various life experiences.
Receives: Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)
Waiting list Control GroupNo interventionThe control group will receive their routine care as usual. Once the trial is completed they will be invited for EMDR sessions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of recruitment

    The feasibility will be determined by collecting data on recruitment rates. The success criterion of feasibility will be to recruit > 50% of eligible participants.

    Measured: From baseline to 8th week (at the end of intervention)

  2. Acceptability measure

    Intervention acceptability will be assessed using data on intervention attendance. The criterion for acceptability is the intervention attendance rate of > 5 sessions.

    Measured: From baseline to 8th week (at the end of intervention)

  3. Feasibility of Retention

    The feasibility of retention will be determined by collecting data on retention rates. The success criterion of feasibility of retention will be to retain > 50% participants.

    Measured: From baseline to 8th week (at the end of intervention)

Secondary outcomes (6)
  1. Beck Scale for Suicide Ideation

    Beck Scale for Suicide Ideation is a 19-item instrument for detecting and measuring the current intensity of patient-specific attitude, behavior, and specificity of patient thoughts to kill themselves during the past week.

    Measured: Change in problem scores from baseline to 8th week

  2. The International Trauma Questionnaire

    The International Trauma Questionnaire is a brief, simple-worded measure focusing on the core features of post-traumatic stress disorder.

    Measured: Change in problem scores from baseline to 8th week

  3. Depression Anxiety and Stress Scale

    Depression Anxiety and Stress Scale is consist of three subscales that measure the negative emotional states of depression, anxiety, and stress and consist of 7 items per subscale. The participants are requested to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week.

    Measured: Change in problem scores from baseline to 8th week

  4. Beck Hopelessness Scale

    Beck hopelessness scale measure three aspects of hopelessness; feelings about the future, loss of motivation and expectations. The scale consists of 20 statements each of which is scored as 0 or 1.

    Measured: Change in problem scores from baseline to 8th week

  5. Sleep Quality Questionnaire

    Sleep Quality Questionnaire consists of eight items rated on a 5-point scale. It measures self-reported alertness, sleepiness, tiredness, and functional impairments associated with sleep and problems during waking hours within the past seven days.

    Measured: Change in problem scores from baseline to 8th week

  6. Coping Resource Inventory

    The Coping Resource Inventory assesses the individual's stress management and coping resources with stress.

    Measured: Change in coping resources scores from baseline to 8th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2021
  2. Study start20 May 2022
  3. Primary completion30 Dec 2024 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05171868
Sponsor's protocol ID
SAHAR M-EMDR-001
Status last verified
May 2024
First submitted
11 Dec 2021
Last updated
17 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Eye Movement Desensitization and Reprocessing (EMDR) in people with Suicidal Ideation and Psychological Trauma, run by Pakistan Institute of Living and Learning at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact MUQADDAS ASIF (042-35842310, muqaddas.asif@pill.org.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of recruitment (time frame: From baseline to 8th week (at the end of intervention)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2024; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in